4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,488 | 60,241 | 48,555 | 77,159 | 133,526 |
| Marketable Securities | 318,404 | 342,414 | 256,508 | 216,066 | 187,911 |
| TOTAL | $405,364 | $413,134 | $312,377 | $303,287 | $332,566 |
| Non-Current Assets | |||||
| PPE Net | 13,587 | 14,867 | 16,153 | 17,505 | 18,745 |
| Investments And Advances | 66,739 | 111,379 | 67,165 | 123,806 | 137,004 |
| Other Non-Current Assets | 27,215 | 27,331 | 28,287 | 29,039 | 27,414 |
| TOTAL | $107,541 | $153,577 | $111,605 | $170,350 | $183,163 |
| Total Assets | $512,905 | $566,711 | $423,982 | $473,637 | $515,729 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,692 | 11,159 | 6,863 | 8,700 | 4,151 |
| Accrued Expenses | 22,866 | 26,874 | 24,189 | 19,190 | 16,203 |
| TOTAL | $43,404 | $43,985 | $37,107 | $34,677 | $26,899 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 360 | 360 | 360 | 1,066 | 866 |
| Other Non-Current Liabilities | 15,540 | 16,317 | 17,057 | 17,851 | 18,673 |
| TOTAL | $17,665 | $17,062 | $17,892 | $18,070 | $19,107 |
| Total Liabilities | $61,069 | $61,047 | $54,999 | $52,747 | $46,006 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,276 | 51,051 | 57,135 | 46,702 | 46,325 |
| Common Shares | 5 | 6 | 5 | 5 | 5 |
| Retained earnings | -785,064 | -716,304 | -735,701 | -678,825 | -624,167 |
| Other shareholders' equity | -180 | 727 | 671 | 337 | 332 |
| TOTAL | $451,836 | $505,664 | $368,983 | $420,890 | $469,723 |
| Total Liabilities And Equity | $512,905 | $566,711 | $423,982 | $473,637 | $515,729 |